The surge of Human Metapneumovirus (HMPV) cases in India, coupled with the absence of any approved vaccine, has spotlighted diagnostic companies as increased testing needs drive demand for molecular diagnostics and respiratory panels. This emerging health concern creates significant opportunities in the diagnostic sector, particularly for firms with established testing infrastructure and virus detection capabilities. … Continue reading Abbott and 6 other diagnostic stocks to benefit from HMPV virus concerns in India